How’s That Stretchy, Bendy Stuff Working Out for Ya? MC10 Looks to Turn Flexible Sensors and Solar Cells Into a Growth Business

Marc Andreessen, the Silicon Valley entrepreneur-turned-venture-capitalist, said something interesting in last weekend’s New York Times magazine interview. It wasn’t his “there’s no tech bubble” spiel, or even his prediction that we’ll all be riding around in self-driving cars in 10 to 20 years, thanks to Google. No, it was that he singled out “wearable computing”—portable … Continue reading “How’s That Stretchy, Bendy Stuff Working Out for Ya? MC10 Looks to Turn Flexible Sensors and Solar Cells Into a Growth Business”

Cyphy Works Secures $1,200,000 New Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4dad5d23-3352-43e2-980b-31fadb14de16&Preview=1 Date 7/12/2011 Company Name Cyphy Works Mailing Address 11 Gage Road Wayland, MA 01778 Company Description The company is a robotics startup that is developing unmanned aerial vehicle technologies. Website http://www.cyphyworks.com Transaction Type Venture Equity Transaction Amount $1,200,000 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. … Continue reading “Cyphy Works Secures $1,200,000 New Financing Round”

Abine Secures $5,200,000 Series A Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=177cc63c-10c6-4913-9a1b-cbbf317f933e&Preview=1 Date 7/12/2011 Company Name Abine Mailing Address 720 Massachusetts Avenue Cambridge, MA 02139 Company Description Abine, Inc., the online privacy company, provides Internet privacy solutions for consumers. Abine’s products and services allow regular people to regain control over their personal information while continuing to browse, interact and shop online. One of … Continue reading “Abine Secures $5,200,000 Series A Funding Round”

Startups Making Do with Fewer Workers, Kauffman Study Shows

Has the air gone out of the American economy? That’s the troubling suggestion of a new study showing how, even before the current downturn, fewer new firms were being formed and those that did open for business were hiring fewer workers. Titled “Starting Smaller, Staying Smaller: America’s Slow Leak in Job Creation,” the report looks … Continue reading “Startups Making Do with Fewer Workers, Kauffman Study Shows”

Fewer Funds Raise More Capital as Venture Industry Contracts Around “Brand Name” VCs

The U.S. venture capital industry is raising more capital for fewer funds so far this year, continuing a contraction in the number of venture firms, according to a couple of rival surveys released today. While the $2.7 billion raised by VC firms during the second quarter marked a 28 percent increase over the $2.1 billion … Continue reading “Fewer Funds Raise More Capital as Venture Industry Contracts Around “Brand Name” VCs”

TripAdvisor Buys Where I’ve Been

Newton, MA-based online travel giant TripAdvisor said today it has acquired Where I’ve Been, a social travel software company based in Chicago. Terms of the deal weren’t disclosed, but the entire product team from Where I’ve Been will join TripAdvisor, according to the press release. Where I’ve Been is best known for its Facebook application … Continue reading “TripAdvisor Buys Where I’ve Been”

LinkedIn’s Reid Hoffman: “How to Benefit 100 Million People”

Details and info here. Designing and Building Human Ecosystems for Networks and Marketplaces Hosted by Joichi Ito. An accomplished entrepreneur, executive, and angel investor, Reid Hoffman has played an integral part in building many of today’s leading consumer-technology businesses. Hoffman was a founding board member and executive at PayPal before he launched LinkedIn from his … Continue reading “LinkedIn’s Reid Hoffman: “How to Benefit 100 Million People””

Shire Gains West Coast Presence with Advanced BioHealing; Looks to Hire 50

After completing its $750 million acquisition of San Diego-based regenerative medicine company Advanced BioHealing (ABH) on June 28th, Irish drug giant Shire (NASDAQ: SHPGY) is going on a minor hiring binge. ABH plans to hire 50 new employees in San Diego, according to ABH CEO Kevin Rakin. The company now employs 256 people at its … Continue reading “Shire Gains West Coast Presence with Advanced BioHealing; Looks to Hire 50”

Qualtré Grabs $10M

Qualtré, a Marlborough, MA-based maker of motion sensors for consumer electronics, said it took in another $10 million in funding, from Matrix Partners and Pilot House Ventures. The investment comes alongside Qualtré’s successful demonstration of what it calls the world’s first tri-axial, solid-state, silicon bulk-acoustic wave gyroscope, which can be used in tablets and smart … Continue reading “Qualtré Grabs $10M”

Gridco Gets $12.5M for Smart Grid

Cambridge, MA-based Gridco has raised $12.5 million in equity financing, according to a regulatory filing. The form lists venture capitalists Ric Fulop of North Bridge Venture Partners and Hemant Taneja of General Catalyst Partners as the company’s directors, along with Naimish Patel, formerly of Sycamore Networks. Back in May, the Boston Globe reported that North … Continue reading “Gridco Gets $12.5M for Smart Grid”

Whereto, China?

I recently had the pleasure of taking a two week academic trip to China with Babson’s MBA program, where several dozen of my classmates and I were led through Beijing, Dalian, and Shanghai by the inimitable Robert Eng. During the course of the journey, our group visited with government officials, leaders from state-owned enterprises, and … Continue reading “Whereto, China?”

The Missing Ingredient in Today’s Biotech: Guts

People in the biotech business (most, anyway) aren’t delusional. They know the odds are stacked against anybody who dares to develop a new drug. But even during the darkest days of recent economic history, December 2008, I heard a seasoned executive explain why the U.S. was, and would remain, the leading place in the world … Continue reading “The Missing Ingredient in Today’s Biotech: Guts”

FluoroPharma Medical Secures $2,355,621 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=724d02c2-d2ff-491b-99f2-8a110149b4ba&Preview=1 Date 7/11/2011 Company Name FluoroPharma Medical Mailing Address 500 Boylston Street Boston, MA 02116 Company Description FluoroPharma, Inc., a privately-held molecular imaging company headquartered in Boston MA, engages in the discovery, development and commercialization of proprietary diagnostic imaging products. The company’s initial focus is the development of breakthrough positron emission tomography … Continue reading “FluoroPharma Medical Secures $2,355,621 New Round”

Gridco Receives $12,500,007 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2eca7759-569c-440e-b012-aaf296e2c167&Preview=1 Date 7/11/2011 Company Name Gridco Mailing Address 20 University Road 4th Floor Cambridge, MA 02138 Company Description Gridco, a new startup focused on smarter power management technology for utilities and industrial power consumers. Website Undisclosed Transaction Type Venture Equity Transaction Amount $12,500,007 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not … Continue reading “Gridco Receives $12,500,007 New Round”

Medtronic to buy Salient for $500M+

Medical device giant Medtronic said it will acquire Salient Surgical Technologies in Portsmouth, NH for $525 million. Established in 1999 and formerly known as Tissuelink Medical, Salient makes devices that stop bleeding and seal wounds by allowing surgeons to apply focused radio-frequency energy and saline solution to collagen fibers in the body. Given Medtronic’s previous … Continue reading “Medtronic to buy Salient for $500M+”

Anatomy of a $256M Acquisition: The Story of DynaTrace, Compuware, and Bain Ventures

Benjamin Nye has an eye for the Benjamins. That’s not quite a palindrome, but it does sum up Nye’s track record as a tech investor. Nye, a managing director with Bain Capital Ventures, has had a string of strong exits—including Network Intelligence (bought by EMC in 2006), SolarWinds (IPO in 2009), and LinkedIn (IPO this … Continue reading “Anatomy of a $256M Acquisition: The Story of DynaTrace, Compuware, and Bain Ventures”

Will Apple’s iCloud Finally Kill Off iTunes and End the Scourge of Sync? My Week in Apple Hell

Xconomy has been around for four years now (our birthday was June 27) and I used the same white plastic MacBook that whole time. It was a great little machine—but despite a memory upgrade, two battery transplants, and a new keyboard (I’m pretty hard on keyboards), it just wasn’t pulling its weight anymore. The OS … Continue reading “Will Apple’s iCloud Finally Kill Off iTunes and End the Scourge of Sync? My Week in Apple Hell”

Avedro Adds $25M for Microwave Vision Correction

Waltham, MA-based Avedro, a medical tech startup, said yesterday it has completed a $25 million Series C financing led by SCP Vitalife and Aperture Venture Partners. Existing investors Prism VentureWorks, De Novo Ventures, Flagship Ventures, Borealis Ventures and Echelon Ventures also participated in the round. Avedro said the money will be used to expand commercial … Continue reading “Avedro Adds $25M for Microwave Vision Correction”

Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News

New England biotechs and devices firms have been active in nabbing partnerships, landing investments, and progressing with clinical programs this week. —Syndax Pharmaceuticals, an epigenetics startup out of Waltham, MA, revealed three sets of data on its lung cancer drug at the Study of Lung Cancer conference this week. The drug, entinostat, is in Phase … Continue reading “Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News”

Healthrageous Garners $2,500,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=79f45e62-9b7e-46ab-8944-271162ba5258&Preview=1 Date 7/8/2011 Company Name Healthrageous Mailing Address 75 Federal St. Boston, MA 02110 Company Description The startup’s software is designed to automatically give people personalized advice to help them reach health goals such as losing weight, lowering blood pressure, or controlling their diabetes. Website http://www.Healthrageous.com Transaction Type Venture Equity Transaction Amount … Continue reading “Healthrageous Garners $2,500,000 New Round”

SpringLeaf Therapeutics Garners $4,000,000 Series B Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=09116e32-bd9f-457b-b1d2-39f8562ff570&Preview=1 Date 7/8/2011 Company Name SpringLeaf Therapeutics Mailing Address 8 St. Mary’s Street Boston, MA 02215 Company Description SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed … Continue reading “SpringLeaf Therapeutics Garners $4,000,000 Series B Funding Round”

Qualtré Secures $10,000,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5c93081c-7886-4eea-94b5-c9ca4ca76639&Preview=1 Date 7/8/2011 Company Name Qualtré Mailing Address 225 Cedar Hill Street Marlborough, MA 01752 Company Description Qualtré Inc. is commercializing the next generation of these inertial sensors, further broadening their applicability in CE devices like cellular handsets, personal navigation devices, and gaming controllers. Using a proprietary high-performance, low-cost technology platform, Qualtré … Continue reading “Qualtré Secures $10,000,000 New Round”

Amylin, Alkermes Once-Weekly Diabetes Drug Passes Heart Trial Demanded by FDA

The diabetes drug that people are counting on at Amylin Pharmaceuticals, Eli Lilly, and Alkermes has passed a crucial test that the FDA demanded almost 10 months ago. San Diego-based Amylin (NASDAQ: [[ticker:AMLN]]), along with its partners, said today that exenatide once-weekly (Bydureon) didn’t appear to cause an irregular heart rhythm, known as QT prolongation, … Continue reading “Amylin, Alkermes Once-Weekly Diabetes Drug Passes Heart Trial Demanded by FDA”

Allegro Gets Another $5.4M

Maynard, MA-based Allegro Diagnostics said today that it has plumped up its Series A financing by another $5.4 million. The money comes from existing investors Kodiak Venture Partners and Catalyst Health Ventures. Allegro is developing a diagnostic platform for lung cancer that uses gene expression of normal epithelial cells in the respiratory tract to detect … Continue reading “Allegro Gets Another $5.4M”

Fate Therapeutics Trims Chemistry Staff, Bets on Biotech Drugs

Fate Therapeutics, the high-profile stem cell startup in San Diego, has made some limited job cuts in recent months and changed strategy to focus on biotech drugs—instead of conventional small molecules—to coax stem cells into becoming a useful therapies. The company, founded by leading scientists at Harvard University, Stanford University, and the University of Washington, … Continue reading “Fate Therapeutics Trims Chemistry Staff, Bets on Biotech Drugs”

RentJuice Seeks to Help Landlords and Brokers Get Serious About the Web, Like Consumers Already Are

David Vivero, the co-founder and CEO of San Francisco-based RentJuice, was raised in the real estate business. His family owns and manages several apartment buildings in Miami Beach. He grew up fixing air conditioners, traipsing up and down the stairs collecting rent checks, and negotiating with tenants over security deposits. Even after he went off … Continue reading “RentJuice Seeks to Help Landlords and Brokers Get Serious About the Web, Like Consumers Already Are”

Zafgen Pockets $33M To Take Obesity Drug Through Next Big Step in Clinical Trials

Obesity drug developer Zafgen is announcing today that it has closed a $33 million Series C financing led by its existing investors, including Third Rock Ventures and Atlas Venture. This doubles the total amount of cash raised by the Cambridge, MA-based startup to $66 million. Zafgen CEO Thomas Hughes says the company will use the … Continue reading “Zafgen Pockets $33M To Take Obesity Drug Through Next Big Step in Clinical Trials”

Microsoft Research New England Turns 3: Jennifer Chayes Reveals Its First Product-and Collaborations With Bing, Facebook, and Twitter

Whether you’re part of the Boston-Cambridge technology community, or just an interested observer, you’ve probably been to the Microsoft New England Research and Development Center (known affectionately as NERD) at least a few times in the past year. But do you know what Microsoft is actually working on there? I didn’t. Until last week, that … Continue reading “Microsoft Research New England Turns 3: Jennifer Chayes Reveals Its First Product-and Collaborations With Bing, Facebook, and Twitter”

Allegro Diagnostics Obtains $5,400,000 Series A Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c49664e6-2ddf-4d6b-9c65-16defd23203c&Preview=1 Date 7/7/2011 Company Name Allegro Diagnostics Mailing Address 6 Clock Tower Place Maynard, MA 01754 Company Description Allegro Diagnostics is a leader in the field of gene expression molecular diagnostic testing for lung cancer and other diseases. Website http://www.allegrodx.com Transaction Type Venture Equity Transaction Amount $5,400,000 Transaction Round Series A Proceeds … Continue reading “Allegro Diagnostics Obtains $5,400,000 Series A Funding”

Avedro Secures $25,000,000 Series C Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=95bbdfc0-c0c2-4206-9531-42e01e282373&Preview=1 Date 7/7/2011 Company Name Avedro Mailing Address 230 Third Avenue Waltham, MA 02451 Company Description Avedro’s Keraflex is not laser eye surgery – it is a non-incisional, non-invasive procedure currently under clinical study for the correction of myopia and the treatment of keratoconus. Unlike LASIK and other laser vision correction procedures, … Continue reading “Avedro Secures $25,000,000 Series C Funding Round”

Zafgen Lands $33,000,000 Series C Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4457e7de-f132-4f30-9d70-dc17c8266a20&Preview=1 Date 7/7/2011 Company Name Zafgen Mailing Address 5 Cambridge Center Floor 2 Cambridge, MA 02142 Company Description The company is developing novel therapeutics for the treatment of obesity. Website http://www.zafgen.com Transaction Type Venture Equity Transaction Amount $33,000,000 Transaction Round Series C Proceeds Purposes Proceeds from the financing will be used to … Continue reading “Zafgen Lands $33,000,000 Series C Round”

EnerNOC Buys Energy Response

EnerNOC (NASDAQ: [[ticker:ENOC]]), the Boston-based provider of energy management and demand response technology, announced today that it has acquired Energy Response, the largest demand response provider in Australia and New Zealand. The deal helps EnerNOC expand its presence in those markets and gives Energy Response customers access to EnerNOC’s applications. The announcement did not reveal … Continue reading “EnerNOC Buys Energy Response”

Rib-X Inks Research Agreement With Sanofi

New Haven, CT-based Rib-X Pharmaceuticals announced today that it could receive about $772 million from Sanofi (NYSE: [[ticker:SNY]]) under a new research collaboration and option for Sanofi to license novel classes of antibiotics from Rib-X’s RX-04 program for the treatment of resistant Gram-negative and resistant Gram-positive infections. Sanofi paid $10 million upfront and could pay … Continue reading “Rib-X Inks Research Agreement With Sanofi”

DynaTrace Acquired by Compuware for $256M to Make Business Software Run Better

Another Boston-area business software company exits the scene today via acquisition. Following in the footsteps of Gomez (and many others), Waltham, MA-based DynaTrace, which helps companies manage the performance of their software applications, has been bought by Detroit-based Compuware (NASDAQ: [[ticker:CPWR]]) for $256 million in cash. The deal closed on July 1. DynaTrace has 180 … Continue reading “DynaTrace Acquired by Compuware for $256M to Make Business Software Run Better”

Alkermes Wins Over Investors With Plan To Become Trans-Atlantic “Big Biotech”

Richard Pops went on hiatus for a while as CEO of Alkermes, and when he returned in September 2009, he vowed to put the company back in “building mode.” It could have been dismissed as rah-rah rhetoric, but over the past couple of months, the investment community has started to rally behind Pops’ bold plan … Continue reading “Alkermes Wins Over Investors With Plan To Become Trans-Atlantic “Big Biotech””

I Love Entrepreneurs, But Not as My Science Teacher

“If you think education is expensive, try ignorance.” It may be just a bumper sticker aphorism, but lately it’s got me thinking. Peter Thiel, early Facebook investor and Paypal cofounder, announced recently that he’s offering $100,000 to 24 young people to drop out of school and pursue an entrepreneurial idea in Silicon Valley. Thiel says … Continue reading “I Love Entrepreneurs, But Not as My Science Teacher”

Zynga Files For IPO, Brightcove Inks Boston Lease, Lotus Adds $26M, & More Boston-Area Deals News

New England biotechs helped make some deals headlines in the last week, while other startups have been a bit quieter surrounding the holiday weekend. —Boston-based cancer drug developer Acetylon Pharmaceuticals nabbed $27 million in Series B financing from individual investors, bringing its funding pot $40 million, including a mix of federal grants, private financing, and … Continue reading “Zynga Files For IPO, Brightcove Inks Boston Lease, Lotus Adds $26M, & More Boston-Area Deals News”

Compuware Acquires dynaTrace for $256,000,000

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1fbef046-55e2-435f-9787-40deb3031c3d&Preview=1 Date 7/6/2011 Company Name dynaTrace Mailing Address 400-1 Totten Pond Rd. Second Floor Waltham, MA 02451 Company Description We provide innovative performance-diagnostics solutions for mission-critical, cross-platform applications. Our mission is to offer top-quality products, excellent service, and unrivalled support worldwide. We are committed to developing company-wide diagnostics solutions that fulfill the … Continue reading “Compuware Acquires dynaTrace for $256,000,000”

Precision Biopsy Obtains $2,500,000 New Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a3cf11f2-0e9b-444f-9b82-d28cf64d38f2&Preview=1 Date 7/6/2011 Company Name Precision Biopsy Mailing Address 33 Arch Street Boston, MA 02110 Company Description Precision Biopsy, LLC was formed in partnership with Allied Minds to develop and commercialize novel technology for the accurate diagnosis of prostate cancer. The company’s diagnostic technology uses advanced spectroscopy imaging techniques in combination with … Continue reading “Precision Biopsy Obtains $2,500,000 New Financing”

TeraDiode, MIT Lincoln Lab Spinoff, Trying to Create the Future of Laser Weapons & Welding

If laser weapons and tools ever become mainstream, it might be because of a quiet little company called TeraDiode. Sure, there are lots of more imminent (and perhaps more practical) applications for the Littleton, MA-based laser firm—welding, cutting metal, illuminating targets, and so forth—but blowing stuff up is what a laser was meant to do. … Continue reading “TeraDiode, MIT Lincoln Lab Spinoff, Trying to Create the Future of Laser Weapons & Welding”

Brightcove Moving to Boston, Looks to Hire

Cambridge, MA-based Brightcove, the digital media and video hosting firm, said today it is planning to move from One Cambridge Center to Atlantic Wharf on the Boston waterfront in April 2012. The company, which was founded in 2004, has signed a 10-year lease for an 82,000-square-foot office space at 290 Congress Street. Brightcove has 280 … Continue reading “Brightcove Moving to Boston, Looks to Hire”

Entrepreneurial Walk of Fame Looking Real-September 16 Launch Targeted

It’s an idea people love the instant they hear it: movies stars have their Walk of Fame out in Hollywood, so entrepreneurs should have one, too—and what better place than right here in Kendall Square, the most fertile, concentrated ground for entrepreneurship in the world? Last August, Xconomy was first to report on the idea … Continue reading “Entrepreneurial Walk of Fame Looking Real-September 16 Launch Targeted”

Syndax Moves Closer to Pivotal Trials of Selective Lung Cancer Treatment

Executives from Syndax Pharmaceuticals are spending their post-holiday week in Amsterdam, where they’ll be presenting three sets of data on the company’s lung cancer drug at the International Association for the Study of Lung Cancer conference. The drug, called entinostat, is in Phase 2 clinical testing, the results of which will be critical to advancing … Continue reading “Syndax Moves Closer to Pivotal Trials of Selective Lung Cancer Treatment”

Blue Cod Technologies Secures $3,000,000 New Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5c1990ee-8c06-492a-8ee1-fce680c9cf63&Preview=1 Date 7/5/2011 Company Name Blue Cod Technologies Mailing Address 295 Donald Lynch Blvd. Marlborough, MA 01752 Company Description Blue Cod Technologies, Inc. delivers Management and IT consulting, innovative software solutions and applications outsourcing services for today’s service industries such as insurance, financial services and utilities. Website http://www.bluecod.net Transaction Type Venture Equity … Continue reading “Blue Cod Technologies Secures $3,000,000 New Round”

Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Second Quarter

Hold on to your lighter fluid there, Mr. Barbecue. Not so fast, Ms. I’m-Leaving-Early-For-The-Cape. Yes, I’m talking to you, Fourth of July holiday slackers. Actually, go ahead and slack off—this should go down pretty easy. At the end of each quarter, we like to look back at some of Xconomy’s top stories. These are not … Continue reading “Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Second Quarter”

Three E-Books That Are Making the iPad Sing, Just in Time for Summer Reading Season

Technology changes quickly, and sometimes, so does my own mind. In January, I wrote a dismissive column about two e-book titles tailored for the Apple iPad, Alice for the iPad and Why the Net Matters. My main beef was that the apps, which had been lauded by the New York Times as “superbooks,” contained more … Continue reading “Three E-Books That Are Making the iPad Sing, Just in Time for Summer Reading Season”

Acetylon Adds $27M, Third Rock Leads Lotus Round, InfraReDx Gets $24M, & More Boston-Area Life Sciences News

New England drug developers, health IT startups, and med devices firms all made life sciences this week. —Genentech brokered a rare deal to obtain an early-stage cancer drug program from Cambridge, MA-based Forma Therapeutics. On top of the more typical upfront payment, development costs coverage, research support, and development milestones, Genentech has the option to … Continue reading “Acetylon Adds $27M, Third Rock Leads Lotus Round, InfraReDx Gets $24M, & More Boston-Area Life Sciences News”